Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 586 | $245,012,579 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
03 May 2022 17:09 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 02 May 2022 | Sale | 1,100 | 656.97 | 722,667 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 3 | 658.09 | 1,974 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 3 | 656.97 | 1,971 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 6 | 655.44 | 3,933 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 1 | 654.21 | 654 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 21 | 653.57 | 13,725 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 14 | 652.71 | 9,138 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 10 | 651.46 | 6,515 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 6 | 650.47 | 3,903 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 5 | 649.62 | 3,248 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 4 | 648.68 | 2,595 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 3 | 647.09 | 1,941 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 7 | 646.49 | 4,525 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 3 | 645.64 | 1,937 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 9 | 644.54 | 5,801 | D |
03 May 2022 17:10 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 02 May 2022 | Sale | 5 | 643.76 | 3,219 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 57 | 670.49 | 38,218 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 153 | 669.12 | 102,375 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 180 | 668.68 | 120,362 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 154 | 667.49 | 102,793 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 352 | 666.23 | 234,513 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 126 | 665.36 | 83,835 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 428 | 664.32 | 284,329 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 472 | 663.6 | 313,219 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 779 | 662.57 | 516,142 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 465 | 661.46 | 307,579 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 77 | 660.32 | 50,845 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 123 | 658.56 | 81,003 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 60 | 657.51 | 39,451 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 58 | 656.52 | 38,078 | D |
18 May 2022 16:05 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 17 May 2022 | Sale | 59 | 655.4 | 38,669 | D |
03 Jun 2022 16:00 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Jun 2022 | Sale | 1,100 | 669.51 | 736,461 | D |
05 Jul 2022 16:03 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Jul 2022 | Sale | 1,100 | 587.76 | 646,536 | D |
02 Aug 2022 16:28 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Aug 2022 | Sale | 1,100 | 581.53 | 639,683 | D |
08 Aug 2022 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 04 Aug 2022 | Sale | 1,410 | 622.06 | 877,105 | D |
08 Aug 2022 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 04 Aug 2022 | Sale | 4,156 | 621.54 | 2,583,120 | D |
08 Aug 2022 16:12 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 04 Aug 2022 | Sale | 4,887 | 620.85 | 3,034,094 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 100 | 621.11 | 62,111 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 177 | 620.11 | 109,759 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 502 | 619.64 | 311,059 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 521 | 618.27 | 322,119 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 424 | 617.43 | 261,790 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 535 | 616.4 | 329,774 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 1,610 | 615.49 | 990,939 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 4,112 | 614.35 | 2,526,207 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,218 | 613.49 | 1,974,211 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 2,076 | 612.43 | 1,271,405 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 2,022 | 611.44 | 1,236,332 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,931 | 610.49 | 2,399,836 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 3,044 | 609.62 | 1,855,683 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 610 | 608.7 | 371,307 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 724 | 607.47 | 439,808 | D |
08 Aug 2022 16:11 | REGN | REGENERON PHARMACEUTICALS Inc | STAHL NEIL | EVP Research and Development | 05 Aug 2022 | Sale | 176 | 606.78 | 106,793 | D |
11 Aug 2022 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 09 Aug 2022 | Sale | 8,186 | 621.27 | 5,085,716 | D |
11 Aug 2022 16:09 | REGN | REGENERON PHARMACEUTICALS Inc | POON CHRISTINE A | Director | 09 Aug 2022 | Sale | 6,814 | 620.47 | 4,227,883 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 86 | 649.54 | 55,860 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 766 | 648.78 | 496,965 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 701 | 647.73 | 454,059 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 325 | 646.44 | 210,093 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 119 | 645.63 | 76,830 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 332 | 644.49 | 213,971 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 94 | 643.37 | 60,477 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 329 | 642.53 | 211,392 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 537 | 641.47 | 344,469 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 148 | 640.91 | 94,855 | D |
17 Aug 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | MURPHY ANDREW J | EVP Research | 16 Aug 2022 | Sale | 76 | 639.85 | 48,629 | D |
02 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | MCCOURT MARION | EVP Commercial | 01 Sep 2022 | Sale | 1,100 | 577.62 | 635,382 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 602 | 584.57 | 351,911 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 1,045 | 583.16 | 609,402 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 1,220 | 582.56 | 710,723 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 822 | 581.44 | 477,944 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 688 | 580.44 | 399,343 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 550 | 579.85 | 318,918 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 273 | 578.25 | 157,862 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 500 | 577.07 | 288,535 | D |
08 Sep 2022 16:06 | REGN | REGENERON PHARMACEUTICALS Inc | COLES N ANTHONY | Director | 06 Sep 2022 | Sale | 300 | 576.73 | 173,019 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 3 | 587.23 | 1,762 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 8 | 586.31 | 4,690 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 16 | 585.58 | 9,369 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 6 | 584.77 | 3,509 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 11 | 583.45 | 6,418 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 8 | 582.51 | 4,660 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 14 | 581.46 | 8,140 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 9 | 580.75 | 5,227 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 7 | 579.67 | 4,058 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 11 | 578.56 | 6,364 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 4 | 577.26 | 2,309 | D |
08 Sep 2022 16:07 | REGN | REGENERON PHARMACEUTICALS Inc | RYAN ARTHUR F | Director | 06 Sep 2022 | Sale | 3 | 576.85 | 1,731 | D |
12 Sep 2022 16:31 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 08 Sep 2022 | Sale | 1,279 | 686.99 | 878,660 | D |
12 Sep 2022 16:31 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 08 Sep 2022 | Sale | 1,279 | 705 | 901,695 | D |
12 Sep 2022 16:31 | REGN | REGENERON PHARMACEUTICALS Inc | BASSLER BONNIE L | Director | 09 Sep 2022 | Sale | 609 | 741 | 451,269 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 79 | 722.83 | 57,104 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 174 | 721.38 | 125,520 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 181 | 720.41 | 130,394 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 159 | 719.72 | 114,435 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 435 | 718.5 | 312,548 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 647 | 717.59 | 464,281 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 1,052 | 716.28 | 753,527 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 861 | 715.39 | 615,951 | D |
13 Sep 2022 16:04 | REGN | REGENERON PHARMACEUTICALS Inc | VAN PLEW DANIEL P | EVP & General Mgr, Industrial | 12 Sep 2022 | Sale | 267 | 714.42 | 190,750 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)